John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AREX
2551
CALL
DELISTED
Approach Resources Inc.
AREX
| $92K | ﹤0.01% |
+14,000
| New | +$96.3K |
|
2552
Safe Bulkers
SB
$863M
| $91K | ﹤0.01% |
25,260
-188,979
| -88% | -$682K |
|
|
EXXI
2553
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $91K | ﹤0.01% |
25,009
-223,189
| -90% | -$780K |
|
2554
Broadwind
BWEN
$104M
| $90K | ﹤0.01% |
18,036
-8,567
| -32% | -$43.6K |
|
2555
Fortress Biotech
FBIO
$96.1M
| $89K | ﹤0.01% |
+1,541
| New | +$64.2K |
|
|
EGLE
2556
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $89K | ﹤0.01% |
+86
| New | +$128K |
|
2557
CALL
Pan American Silver
PAAS
$22B
| $88K | ﹤0.01% |
+10,000
| New | +$103K |
|
|
BAS
2558
DELISTED
Basis Energy Services, Inc.
BAS
| $88K | ﹤0.01% |
22
-161
| -88% | -$604K |
|
2559
GSI Technology
GSIT
$222M
| $87K | ﹤0.01% |
14,817
-1,600
| -10% | -$8.78K |
|
|
GLBR
2560
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $84K | ﹤0.01% |
+3,940
| New | +$179K |
|
2561
PUT
Cleveland-Cliffs
CLF
$6.72B
| $82K | ﹤0.01% |
+17,000
| New | +$110K |
|
2562
ICL Group
ICL
$7.43B
| $78K | ﹤0.01% |
10,944
-150,986
| -93% | -$1.08M |
|
2563
CALL
Petrobras
PBR
$120B
| $78K | ﹤0.01% |
+13,000
| New | +$82.9K |
|
|
BV
2564
DELISTED
Bazaarvoice, Inc.
BV
| $76K | ﹤0.01% |
13,416
-35,064
| -72% | -$270K |
|
2565
Arcos Dorados Holdings
ARCO
$1.72B
| $74K | ﹤0.01% |
15,519
-26,646
| -63% | -$136K |
|
|
MPO
2566
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
| $72K | ﹤0.01% |
8,426
+7,047
| +511% | +$79.5K |
|
|
YUME
2567
DELISTED
YuMe, Inc.
YUME
| $71K | ﹤0.01% |
13,633
-7,062
| -34% | -$38.3K |
|
2568
Entravision Communication
EVC
$747M
| $68K | ﹤0.01% |
10,745
-115,875
| -92% | -$766K |
|
2569
Mizuho Financial
MFG
$125B
| $66K | ﹤0.01% |
18,621
-102,447
| -85% | -$359K |
|
2570
QuinStreet
QNST
$1.2B
| $66K | ﹤0.01% |
11,100
-18,168
| -62% | -$111K |
|
|
OCLR
2571
DELISTED
Oclaro Inc.
OCLR
| $66K | ﹤0.01% |
+33,214
| New | +$55.5K |
|
2572
Advanced Micro Devices
AMD
$751B
| $65K | ﹤0.01% |
+24,100
| New | +$67.8K |
|
|
NTLS
2573
DELISTED
NTELOS HLDGS CORP COM
NTLS
| $65K | ﹤0.01% |
13,621
-88,868
| -87% | -$419K |
|
|
SPDC
2574
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
| $60K | ﹤0.01% |
+94,319
| New | +$145K |
|
|
GSOL
2575
DELISTED
Global Sources Ltd
GSOL
| $59K | ﹤0.01% |
10,039
-4,816
| -32% | -$27.8K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.